Key points are not available for this paper at this time.
Verapamil's profile suggests a fourth antiarrhythmic class; leaves open clinical translation from in vitro data alone.
Journal Article A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function Get access B. N. SINGH, B. N. SINGH From the Department of Pharmacology, University of Oxford Search for other works by this author on: Oxford Academic PubMed Google Scholar E. M. VAUGHAN WILLIAMS E. M. VAUGHAN WILLIAMS From the Department of Pharmacology, University of Oxford Search for other works by this author on: Oxford Academic PubMed Google Scholar Cardiovascular Research, Volume 6, Issue 2, March 1972, Pages 109–119, https://doi.org/10.1093/cvr/6.2.109 Published: 01 March 1972
No takes yet. Share an insight, caveat, or question.
Singh et al. (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: